Flora Growth CORP Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
SCHEDULE: ZeroStack Corp. CEO Boosts Stake
Daniel Reis-Faria, CEO of ZeroStack Corp., has increased his beneficial ownership to 37.5% through the exercise of pre-funded warrants and a significant stock option grant.
Dany Vaiman, CFO of ZeroStack Corp., reports beneficial ownership of 513,249 shares (2.9%) and details a shareholder-approved stock option grant tied to VWAP performance.
Michael Heinrich and Zero Gravity Labs Inc. report beneficial ownership of 30.2% and 26.4% of ZeroStack Corp. common shares respectively, totaling over 56% combined.
Michael Heinrich and Zero Gravity Labs Inc. have filed an amendment to their Schedule 13D concerning ZeroStack Corp., detailing a note settlement agreement and beneficial ownership.
Flora Growth Corp. granted its Chairman and CEO, Michael Heinrich, 471,208 stock options with an exercise price of $7.31 per share, vesting upon specific volume weighted average price thresholds.
Flora Growth Corp.'s CFO, Dany Vaiman, increased his beneficial ownership to 23.8% through a grant of 235,604 stock options with performance-based vesting.
Flora Growth Corp.'s CEO, Daniel Reis-Faria, was granted 471,208 stock options with an exercise price of $7.31, vesting upon specific volume-weighted average price thresholds.
Michael Heinrich and Zero Gravity Labs Inc. have acquired beneficial ownership of 87.0% of Flora Growth Corp.'s common shares through a $150 million convertible note.
Flora Growth Corp.'s CEO, Daniel Reis-Faria, has acquired a significant 89.3% beneficial ownership stake in the company through the purchase of pre-funded warrants.
Clifford Starke, CEO and director of Flora Growth Corp., has filed an amended Schedule 13D, disclosing a beneficial ownership of 17.1% of the company's common shares, totaling 3,850,886 shares.
Flora Growth Corp.'s Chief Financial Officer, Dany Vaiman, has updated his beneficial ownership stake in the company to 4.8% of common shares, reflecting an increase in the issuer's total outstanding shares.